REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 266.10
Bid: 265.70
Ask: 265.80
Change: 5.00 (1.91%)
Spread: 0.10 (0.038%)
Open: 263.70
High: 266.10
Low: 262.30
Prev. Close: 261.10
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

10 Jan 2018 09:33

RNS Number : 4754B
Marks & Spencer Group PLC
10 January 2018
 

 

 

 

Issued: Wednesday 10 January 2018

 

Press Release

Marks and Spencer Group plc appoints Chief Finance Officer

 

Marks and Spencer Group plc (M&S) announces the appointment of Humphrey Singer to its Board as Chief Finance Officer. Humphrey, who is currently Group Finance Director at Dixons Carphone plc, will take up his appointment on a date to be confirmed.

 

Humphrey has been Group FD of Dixons Carphone plc since 2014 following the merger of Dixons Retail with Carphone Warehouse Group. He became Group Finance Director of Dixons in 2011, having held several other finance roles since joining the company in 2007. Humphrey's early career included finance roles at Cadbury Schweppes plc and Coca-Cola Enterprises UK Limited. Humphrey is a Non-Executive Director at Taylor Wimpey plc.

 

Steve Rowe, Chief Executive, M&S, said: "As we embark on our five-year transformation programme, Humphrey will be a great addition to the top team. His experience as part of the team that led Dixons through its period of change and migration to multi-channel retailer is most relevant to what we are undertaking here. This, coupled with his retail expertise and eye for detail and cost, will be very important to our team dynamic as we move forward."

 

Humphrey Singer said: "Under Steve M&S is changing and there's no better time to be joining the team that is transforming the business."

 

Humphrey will replace Helen Weir who, as previously announced, is leaving M&S to pursue a portfolio career. Today her leaving date is confirmed as 31st March 2018.

 

Steve Rowe added: "I'd like to take this opportunity to thank Helen for her significant contribution to M&S over the last three years and wish her all the very best for the future."

 

-Ends-

 

 

 

For further information, please contact:

 

 

Enquiries:

Media +44 (0) 208 718 1919

Investor Relations +44 (0) 203 884 70 80

 

 

Notes to Editors:

Remuneration

 

The following information is provided in accordance with section 430(2B) of the Companies Act 2006:

 

Humphrey Singer

 

· On appointment Humphrey will receive an annual salary of £600,000 with no further fixed-pay cash benefits or allowances.

· In accordance with M&S' remuneration policy, he will be eligible to participate in the Annual Bonus Scheme and Performance Share Plan in line with his start date.

 

Helen Weir

 

· Helen Weir's remuneration terms will be in line with her service agreement and the relevant provisions of the Marks and Spencer Group plc's Executive Remuneration Policy approved by shareholders in 2017.

· Helen Weir will continue in her role until 31 March 2018 and, in line with her service agreement, she will receive salary and benefits, including pension, by way of phased monthly payments (subject to mitigation) from 1 April until 8 November 2018, reflecting the remaining period of contractual notice.

· Helen Weir will remain eligible for consideration for payment of an annual bonus for 2017/18, subject to performance.

· Any unvested nil-cost options awarded to Helen Weir under the Deferred Share Bonus Plan will vest in full on termination and may then be exercised in accordance with the Plan rules.

· Any unvested nil-cost options awarded in 2015 and 2016 under the Performance Share Plan will be time pro-rated and will vest, subject to performance conditions on a wait and see basis at the normal vesting date and may then be exercised in accordance with the Plan rules. The award made in 2017 will lapse on leaving in accordance with the Plan rules.

 

Further details of the operation of the Deferred Share Bonus Plan and Performance Share Plan are set out in the Directors' Remuneration Report in our Annual Report and Financial Statements 2017. Full disclosure of these remuneration arrangements will be provided in our Directors' Remuneration Report in 2018.

 

 

- Ends -

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGMMLGZGRZG
Date   Source Headline
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSBlock listing Interim Review
2nd Jan 20249:00 amRNSTotal Voting Rights
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding
7th Jul 20234:18 pmRNSDirector/PDMR Shareholding
4th Jul 20232:13 pmRNSResult of AGM
3rd Jul 20239:00 amRNSTotal Voting Rights
3rd Jul 20239:00 amRNSBlock listing Interim Review
28th Jun 20232:01 pmRNSDirector/PDMR Shareholding
19th Jun 20234:41 pmRNSDirector/PDMR Shareholding
8th Jun 20235:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.